ClearPoint Neuro, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $37.0 | $31.4 | $24.0 | $20.6 | $16.3 |
| Operating income | -$24.2 | -$19.7 | -$22.4 | -$16.3 | -$13.4 |
| Net income | -$25.5 | -$18.9 | -$22.1 | -$16.4 | -$14.4 |
| Balance Sheet | |||||
| Total debt | $50.9 | — | $10.0 | $10.0 | $10.0 |
| Cash Flow Statement | |||||
| Free cash flow | -$24.4 | -$9.2 | -$14.4 | -$16.4 | -$12.9 |
Shares outstanding 30.5M · Free float 39.1%
Annual filing data through FY ended December 31, 2025; float as of September 27, 2026.